There are 2789 resources available
200TiP - ELEANOR: A multi-national, prospective, non-interventional study (NIS) in patients with human epidermal growth factor receptor (HER2) positive, early breast cancer (eBC) observing real-life extended adjuvant treatment with neratinib and concurrent use of the eHealth solution CANKADO
Presenter: Nadia Harbeck
Session: ePoster Display
224P - Value of bone scintigraphy in breast cancer patients staged with computed tomography
Presenter: Vladislav Evseev
Session: ePoster Display
225P - Prognostic factors of luminal A and luminal B intrinsic breast cancer subtypes of Croatian patients: A 5-year experience from Osijek
Presenter: Raffaella Gudelj
Session: ePoster Display
Resources:
Abstract
226P - Elderly breast cancer treated with standard curative intent treatment: An analysis of predictors of disease-free survival (DFS)
Presenter: Sai Kumar Soman
Session: ePoster Display
227P - Risk of breast cancer understaging through standard clinical and radiographic staging in Botswana
Presenter: Isaac Nkele
Session: ePoster Display
231P - Prognosis and efficacy of frontline treatment for HR+ HER2- metastatic breast cancer occurring in gBRCA1/2 carriers
Presenter: Jean-Sebastien Frenel
Session: ePoster Display
232P - Longitudinal circulating tumor DNA (ctDNA) analysis in the phase 1b MONALEESASIA study of ribociclib (RIB) + endocrine therapy (ET) in Asian patients (pts) with hormone receptor–positive (HR+)/human epidermal growth factor receptor 2–negative (HER2–) advanced breast cancer (ABC)
Presenter: Yoon Sim Yap
Session: ePoster Display
234P - Effect of palbociclib (PAL) + endocrine therapy (ET) on time to chemotherapy (TTC) across subgroups of patients (pts) with hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced breast cancer (ABC): Post hoc analyses from PALOMA-2 (P2) and PALOMA-3 (P3)
Presenter: Hope Rugo
Session: ePoster Display